Cargando…
Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates
Glioblastoma multiforme is the most frequent primary malignancy of the central nervous system. Despite remarkable progress towards an understanding of tumor biology, there is no efficient treatment and patient outcome remains poor. Here, we present a unique anti-proteomic approach for selection of n...
Autores principales: | Jovčevska, Ivana, Zupanec, Neja, Urlep, Žiga, Vranič, Andrej, Matos, Boštjan, Stokin, Clara Limbaeck, Muyldermans, Serge, Myers, Michael P., Buzdin, Anton A., Petrov, Ivan, Komel, Radovan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546469/ https://www.ncbi.nlm.nih.gov/pubmed/28498803 http://dx.doi.org/10.18632/oncotarget.17390 |
Ejemplares similares
-
The OncoFinder algorithm for minimizing the errors introduced by the high-throughput methods of transcriptome analysis
por: Buzdin, Anton A., et al.
Publicado: (2014) -
TRIM28 and β-Actin Identified via Nanobody-Based Reverse Proteomics Approach as Possible Human Glioblastoma Biomarkers
por: Jovčevska, Ivana, et al.
Publicado: (2014) -
Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting
por: Samec, Neja, et al.
Publicado: (2018) -
TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion
por: Porčnik, Andrej, et al.
Publicado: (2021) -
Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast
por: Vogelsang, Matjaz, et al.
Publicado: (2009)